Biogénesis Bagó, the biotechnology corporate specialised within the construction, manufacturing and commercialization of answers for animal well being, has acquired EuFMD prequalification for its foot-and-mouth illness vaccine BIOAFTOGEN®, changing into the primary corporate on the planet to obtain this certification granted by means of the Eu initiative that advocates for the keep an eye on of foot-and-mouth illness within the continent.
The Eu Fee for the Regulate of Foot and Mouth Illness is continuously running in conjunction with international locations within the area to put into effect more than a few insurance policies to keep an eye on and save you the specter of FMD and different transboundary sicknesses and advertise the innovative keep an eye on of this illness globally, all inside the framework of the World FMD Regulate Technique of FAO and the International Group for Animal Well being (WOAH). Aligned with this technique, in 2021 the group established a vaccine prequalification device (PQv) in opposition to transboundary sicknesses (FAST) that seeks to make sure the availability of high quality FMD vaccines on behalf of member states.
The prequalification acquired by means of Biogénesis Bagó is a brand new success within the corporate’s lengthy historical past within the prevention and keep an eye on of animal sicknesses, for the reason that for greater than 70 years has been dedicated to the analysis and construction of answers for the struggle in opposition to foot and mouth illness, amongst others. This monitor report has located BIOAFTOGEN® as a world-class vaccine that meets the standard requirements established by means of probably the most difficult well being organizations on the planet.
This success complements the corporate´s place as an international chief in FMD prevention and reinforces its dedication to the collaboration with main technical and medical organizations, contributing to meals protection and animal well being standing international.
November 15, 2023 – Biogénesis Bagó